Rumors are circulating within the astronautical community that NASA are studying the prospective benefits of 2-CB, a copyright drug , to address the difficulties of long-duration space missions. Preliminary reports suggest the organization is evaluating its ability to lessen mental anxiety and enhance team efficiency on future far-reaching voyages